Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Finance

Earnings snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

Nuveen Short Duration Credit Opportunity Fund declares $0.111 dividend
Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

More on Novartis Novartis' Pipeline Building Continues, Pelacarsen Readout Coming Soon Novartis: 'Hold' On Continued Generic Erosion And Need For H2 2026 Catalysts Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely Novartis beats top-line and bottom-line estimates; reaffirms FY26 outlook Novartis Q2 2026 Earn...

Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

Read full story on Seeking Alpha

Related News

More stories you might be interested in.

3 photonics companies making quantum tech possible
MarketBeat·19 hours ago

3 photonics companies making quantum tech possible

Key Points Interested in Lumentum Holdings Inc.? Here are five stocks we like better. Photonics technology is gaining investor attention for powering AI data throughput today and potentially quantum computing applications in the future. Lumentum Holdings has doubled year to date and grew revenue nearly 90% year over year, though shares trade at a lofty valuation near 142x earnings. Smaller peers IPG Photonics and nLight also posted strong growth...

Top